孕妇的血液动力学对妊娠期糖尿病的治疗有因果影响吗?
Abigail R Anness1, Michael Foster2, Mohammed W Osman1
1Maternal and Fetal Medicine Unit, University Hospitals of Leicester NHS Trust, Leicester, UK.
概括
预订时的孕产妇BMI因果影响了妊娠糖尿病 (GDM) 药物治疗的需要. 更高的BMI增加了需要药物治疗GDM的可能性,突出了其在GDM管理中的重要性.
科学领域:
- 在怀孕期间心血管适应.
- 代谢障碍和怀孕情况
- 临床产科和妇科 临床产科和妇科
背景情况:
- 动脉硬化与胰岛素抵抗性恶化有关.
- 与GDM治疗相关的肥胖和年龄等因素可能会损害心血管适应.
- 孕期糖尿病 (GDM) 的管理往往需要除了饮食之外的干预.
研究的目的:
- 调查母亲的血液动力学和GDM治疗需求之间的因果关系.
- 为了确定母体生理标记是否预测需要药理GDM治疗.
主要方法:
- 这是一项对120名患有GDM的女性的观察研究.
- 通过使用Arteriograph®和NICOM®生物反应来评估母亲的血液动力学.
- 用于统计分析的因果推断技术.
主要成果:
- 孕产妇预订身体质量指数 (BMI) 因果影响GDM治疗需求.
- 体重指数 (BMI) 每增加一个单位,就会使需要药物的几率提高12%.
- 虽然心率和脉冲波速度在药物治疗组中较高,但这些并没有显示出因果关系.
结论:
- 预订时的母亲BMI与需要药理GDM治疗的需要有因果关系.
- 在母亲的血液动力学和GDM药物治疗需求之间没有发现显著的因果关系.
相关概念视频
Pathophysiology of Diabetes
935
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
935
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Management and Pharmacotherapy
283
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
283
Hypoglycemia and Glucagon
262
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
262
Hormonal Regulation
33.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.1K


